---
title: "REGAN DANIEL PAUL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/607ff67e-ad73-537a-acd4-d7e23f8d1ca1
json: https://whiteintel.dev/api/public/dossier/607ff67e-ad73-537a-acd4-d7e23f8d1ca1
identifier: sec:0001571320
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# REGAN DANIEL PAUL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001571320`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/607ff67e-ad73-537a-acd4-d7e23f8d1ca1  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/607ff67e-ad73-537a-acd4-d7e23f8d1ca1  

## Ownership & control

### Holdings / subsidiaries

- **KERYX BIOPHAMAEUTICALS INC** (director) — https://whiteintel.dev/entity/bd3a82f7-ca3e-527d-a069-ae188156d413
- **INTERCEPT PHARMACEUTICALS INC** (officer) — https://whiteintel.dev/entity/7e041d37-2a0c-51c6-8d1f-e81aa7212ab3

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **REGAN DANIEL PAUL**. Human view: https://whiteintel.dev/entity/607ff67e-ad73-537a-acd4-d7e23f8d1ca1 · Structured JSON: https://whiteintel.dev/api/public/dossier/607ff67e-ad73-537a-acd4-d7e23f8d1ca1._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._